remedesivir

WHO-led COVID drug scheme doubles down on antibodies, steroids and shuns remdesivir

by
WHO-led COVID drug scheme doubles down on antibodies, steroids and shuns remdesivir

BRUSSELS: A World Health Organization-led scheme to supply COVID-19 drugs to poor countries is betting on experimental monoclonal antibody treatments and steroids but is shunning Gilead’s remdesivir blockbuster therapy, an internal document shows. The WHO draft document, seen by Reuters and dated Oct. 30, says the priorities are to secure monoclonal antibodies in a tight … Read more

What We’ve Learned About Treating COVID

by
What We’ve Learned About Treating COVID

Sept. 10, 2020 — This past spring, health care providers at hospitals around the country scrambled to treat people who were critically ill with a virus they’d only just heard of themselves. Usually, when a severely ill person arrives at the hospital, doctors already know or can quickly find established guidelines, based on years of … Read more